International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Global mRNA Vaccines and Therapeutics Market Research Report 2023-2028:
According to the latest report by IMARC Group, titled " mRNA Vaccines and Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
," the global mRNA vaccines and therapeutics market size reached US$ 56.1 Billion in 2022.
Messenger Ribonucleic Acid (mRNA) is a single-stranded RNA molecule that plays a vital role in human biology, especially in protein synthesis. Numerous mRNA vaccines and therapeutics are now available in the market that are administered in the human body to trigger virus-detecting immune sensors. This is executed to induce the production of antibodies that further bind to the potential pathogens.
These solutions use genetic information to produce viral antigen proteins within the cells and provide acquired immunity through an RNA containing vector, such as lipid nanoparticles. Their use aids in boosting the immunity of the body by improving B- and T-cell responses.
Request for a PDF sample of this report:
https://www.imarcgroup.com/mrna-vaccines-therapeutics-market/requestsample
Global mRNA Vaccines and Therapeutics Market Trends: mRNA vaccines represent a promising alternative to conventional vaccines due to their high potency, capacity for rapid development and potential for low-cost manufacture. Along with this, there has been a rise in the requirement of vaccines and therapeutics for the treatment of various viral infections, such as Ebola and Human Immunodeficiency Virus (HIV). Since these therapeutics are considered to be more effective against pathogens due to their enhanced immunogenicity, numerous private and public companies are heavily investing in extensive research and development (R&D) activities in the field of biotechnology for vaccine development and protein replacement therapy using mRNA.
Additionally, on account of the outbreak of the coronavirus disease (COVID-19) pandemic, numerous companies are currently engaging in the development of a vaccine to curb the transmission of the virus, thereby creating a positive outlook for the market. Moderna, Inc. is one such leading mRNA technology firm that is actively invested in the development of the mRNA-1273 vaccine against the novel coronavirus (SARS-CoV-2). It has registered positive interim results in its Phase 1 study and has already proceeded with the Phase 3 study of mRNA-1273 that is being conducted in collaboration with the NIH and BARDA. The market is further driven by the significant improvements in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA.
Looking forward, IMARC Group expects the market is anticipated to reach a value of US$ 66.2 Billion by 2028. View Report TOC, Figures and Tables: https://www.imarcgroup.com/mrna-vaccines-therapeutics-market
Key Market Segmentation
The research report includes the following segments:
Breakup by Vaccine Type:
• Self-amplifying mRNA-Based Vaccines
• Conventional Non-Amplifying mRNA-Based Vaccines
Breakup by Treatment Type:
• Bioengineered Vaccine
• Gene Therapy
• Gene Transcription
• Cell Therapy
• Monoclonal Antibody
• Others
Breakup by Vaccine Manufacturing:
• In-House
• Out-Sourced
Breakup by Application:
• Cancer
• Infectious Disease
• Gene Editing
• Protein Replacement
Breakup by End-User:
• Hospitals and Clinics
• Research Organizations
• Others
Breakup by Region:
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
Competitive Landscape with Key Players:
• Arcturus Therapeutics Inc
• BioNTech SE
• CureVac AG
• eTheRNA immunotherapies NV
• ethris GmbH
• GlaxoSmithKline PLC
• Moderna Therapeutics Inc
• Translate Bio Inc
• Argos Therapeutics, Inc
• Sangamo Therapeutics Inc
• Pfizer Inc
• etc
1. What was the size of the global mRNA vaccines and therapeutics market in 2022?
2. What is the expected growth rate of the global mRNA vaccines and therapeutics market during 2023-2028?
3. What are the key factors driving the global mRNA vaccines and therapeutics market?
4. What has been the impact of COVID-19 on the global mRNA vaccines and therapeutics market?
5. What is the breakup of the global mRNA vaccines and therapeutics market based on the vaccine type?
6. What is the breakup of the global mRNA vaccines and therapeutics market based on the treatment type?
7. What is the breakup of the global mRNA vaccines and therapeutics market based on vaccine manufacturing?
8. What is the breakup of the global mRNA vaccines and therapeutics market based on the application?
9. What is the breakup of the global mRNA vaccines and therapeutics market based on the enduser?
10. What are the key regions in the global mRNA vaccines and therapeutics market?
11. Who are the key players/companies in the global mRNA vaccines and therapeutics market?
5.3.2
5.3.3
5.3.4
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
